Please use this identifier to cite or link to this item:
https://doi.org/10.1111/bcp.13218
| Title: | Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer | Authors: | Aminkeng, Folefac Ross, Colin JD Rassekh, Shahrad R Rieder, Michael J Bhavsar, Amit P Sanatani, Shubhayan Bernstein, Daniel Hayden, Michael R Amstutz, Ursula Carleton, Bruce C |
Keywords: | Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy anthracycline anthracycline-induced cardiotoxicity cancer chemotherapy clinical practice guidelines congestive heart failure pharmacogenomic screening DOXORUBICIN-INDUCED CARDIOTOXICITY RECOMMENDATIONS UGT1A6 IDENTIFICATION REACTIVITY METABOLITE TOXICITY CHILDREN GRADE CELLS |
Issue Date: | 1-May-2017 | Publisher: | WILEY | Citation: | Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Rieder, Michael J, Bhavsar, Amit P, Sanatani, Shubhayan, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C (2017-05-01). Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 83 (5) : 1143-1145. ScholarBank@NUS Repository. https://doi.org/10.1111/bcp.13218 | Source Title: | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | URI: | https://scholarbank.nus.edu.sg/handle/10635/235058 | ISSN: | 0306-5251 1365-2125 |
DOI: | 10.1111/bcp.13218 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| BCP-83-1143.pdf | 168.82 kB | Adobe PDF | CLOSED | Published |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.